JonesTrading Institutional Services LLC | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,289 results for “JonesTrading Institutional Services LLC”

Femasys Raises $4.5 Million to Advance Women's Health Technologies Including FemBloc Birth Control

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

BioAdaptives' Zeranovia Receives IRB Approval for Human Clinical Trial in Weight Management

BioXcel Therapeutics Secures $14M Through Direct Stock Offering to Institutional Investors

Novartis Q2 Earnings Beat Drives Institutional Accumulation as Pipeline Readouts Loom

Ghana Approves and Releases Genetically Modified Cowpea 'Songotra T' to Combat Crop Losses

Terns Pharmaceuticals Gains Institutional Interest as Stock Surges 830% Following Pipeline Updates

Bridge Biotherapeutics Pivots to Bitcoin Treasury Strategy Following Clinical Trial Failures

Curis Secures $20.2 Million Funding to Advance Emavusertib Cancer Pipeline Following Positive AML Trial Results

Page 1 of 481